Status: current, Defined. Date: 31-Aug 2012. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3073821000168118 | Optiray-350 Ultraject (ioversol 741 mg / 1 mL) injection, 30 mL syringe (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3073831000168115 | Optiray-350 Ultraject 741 mg (iodine 350 mg)/mL injection, 30 mL syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Optiray-350 Ultraject 741 mg (iodine 350 mg)/mL injection, 30 mL syringe | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| Optiray-350 Ultraject 741 mg (iodine 350 mg)/mL injection, 30 mL syringe | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Optiray-350 Ultraject 741 mg (iodine 350 mg)/mL injection, 30 mL syringe | Is a | Optiray-350 Ultraject | true | Inferred relationship | Some | ||
| Optiray-350 Ultraject 741 mg (iodine 350 mg)/mL injection, 30 mL syringe | Is a | ioversol 741 mg / 1 mL injection, 30 mL syringe (medicinal product unit of use) | true | Inferred relationship | Some | ||
| Optiray-350 Ultraject 741 mg (iodine 350 mg)/mL injection, 30 mL syringe | has manufactured dose form | injection solution | false | Inferred relationship | Some | ||
| Optiray-350 Ultraject 741 mg (iodine 350 mg)/mL injection, 30 mL syringe | has unit of use | syringe | true | Inferred relationship | Some | 1562900237 | |
| Optiray-350 Ultraject 741 mg (iodine 350 mg)/mL injection, 30 mL syringe | has Australian BoSS | ioversol | true | Inferred relationship | Some | 1562900236 | |
| Optiray-350 Ultraject 741 mg (iodine 350 mg)/mL injection, 30 mL syringe | has intended active ingredient | ioversol | true | Inferred relationship | Some | 1562900236 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Optiray-350 Ultraject 741 mg (iodine 350 mg)/mL injection, 30 mL syringe | has TPUU | True | Optiray-350 Ultraject 741 mg (iodine 350 mg)/mL injection, 30 mL syringe | Inferred relationship | Some | 1 |
| Optiray-350 Ultraject 741 mg (iodine 350 mg)/mL injection, 30 mL syringe | has TPUU | True | Optiray-350 Ultraject 741 mg (iodine 350 mg)/mL injection, 30 mL syringe | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR